Skip to content

Association between right heart size in and right ventricular pump function in pulmonary arterial hypertension

Association between right heart size in and right ventricular pump function in pulmonary arterial hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00029755
Enrollment
50
Registered
2022-08-26
Start date
2022-09-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I27.0

Interventions

Group 1: Echocardiography and right heart catheterization in patients with pumonary arterial hypertension

Sponsors

Thoraxklinik Heidelberg gGmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Invasive diagnosed PAH (mPAP >= 25mmHg, PAWP = 3WU) Patients that receive a change oder dosis escalation in their drug-based therapy for PAH

Exclusion criteria

Exclusion criteria: Patients younger than 18 years, patient unable to give consent, pregnant patients, relevant comorbidities that speak against the diagnosis PAH

Design outcomes

Primary

MeasureTime frame
Correlation between right heart size based on the RA and RV area and the right ventricular pump function (cardiac output)

Secondary

MeasureTime frame
• Tricuspid annular plane systolic excursion (TAPSE) • Systolic pulmonary arterial pressure (sPAP) • Qualitative RV pump function • RAP, RV pressure • systolic, diastolic und medium PAP • PAWP • Cardiac Output (CO), Cardiac Index (CI) • stroke volume • Pulmonal arterial Compliance (PAC) • maximum pulse (measured using a stress catheter or spiroergometry) • PA-oxygen saturation

Countries

Germany

Contacts

Public ContactEkkehard Grünig

Thoraxklinik Heidelberg gGmbH

ekkehard.gruenig@med.uni-heidelberg.de+49 6221 396 8053

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026